157 related articles for article (PubMed ID: 38125480)
41. Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron.
Kirca F; Aydoğan S; Gözalan A; Kayipmaz AE; Özdemir FAE; Tekçe YT; Beşer İO; Gün P; Ökten RS; Dinç B
Rev Assoc Med Bras (1992); 2022; 68(10):1476-1480. PubMed ID: 36417656
[TBL] [Abstract][Full Text] [Related]
42. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
43. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
44. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
45. Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.
Meo SA; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9470-9476. PubMed ID: 37843359
[TBL] [Abstract][Full Text] [Related]
46. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
47. [Clinical characteristics of neonates infected with the Omicron variant of SARS-CoV-2: a multicenter cross-sectional survey].
Shenzhen Neonatal Data Network
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):678-684. PubMed ID: 37529948
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service.
Radhakrishnan N; Liu M; Idowu B; Bansari A; Rathi K; Magar S; Mundhra L; Sarmiento J; Ghaffar U; Kattan J; Jones R; George J; Yang Y; Southwick F
BMC Infect Dis; 2023 Oct; 23(1):747. PubMed ID: 37907849
[TBL] [Abstract][Full Text] [Related]
49. Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China.
Sha J; Meng C; Sun J; Sun L; Gu R; Liu J; Zhu X; Zhu D
J Infect Public Health; 2023 Mar; 16(3):422-429. PubMed ID: 36731245
[TBL] [Abstract][Full Text] [Related]
50. Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2.
Hirotsu Y; Kakizaki Y; Saito A; Tsutsui T; Hanawa S; Yamaki H; Ide S; Kawaguchi M; Kobayashi H; Miyashita Y; Omata M
Commun Med (Lond); 2023 Feb; 3(1):32. PubMed ID: 36841870
[TBL] [Abstract][Full Text] [Related]
51. Clinical features of COVID-19 in Italian outpatient children and adolescents during Parental, Delta, and Omicron waves: a prospective, observational, cohort study.
Di Chiara C; Boracchini R; Sturniolo G; Barbieri A; Costenaro P; Cozzani S; De Pieri M; Liberati C; Zin A; Padoan A; Bonfante F; Kakkar F; Cantarutti A; Donà D; Giaquinto C
Front Pediatr; 2023; 11():1193857. PubMed ID: 37635788
[TBL] [Abstract][Full Text] [Related]
52. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N
J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949
[TBL] [Abstract][Full Text] [Related]
53. [Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China].
Qi ZH; Bei ZF; Teng S; Wang HP; Li W; Zhao SY; Liu SR
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1092-1097. PubMed ID: 36305108
[TBL] [Abstract][Full Text] [Related]
54. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
[TBL] [Abstract][Full Text] [Related]
55. [Clinical characteristics of children with SARS-CoV-2 Omicron variant infection in Kunming].
Yang JW; Tang CH; Dai M; Duan J; Li YH; Yang J; Yang T; Gao Y; Ban D; Zhu JC; Yuan TY; Li Y; Fu HM
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):922-927. PubMed ID: 37803860
[No Abstract] [Full Text] [Related]
56. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
57. Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants.
Giannitsioti E; Mavroudis P; Speggos I; Katsoulidou A; Pantazis N; Loupis T; Daniil I; Rekleiti N; Damianidou S; Louka C; Sidiropoulou C; Kranidiotis G; Velentza L; Stamati A; Kasidiaraki M; Efstratiadi E; Linardaki G; Chrysos G; Zarkotou O; Zoi K; Tryfinopoulou K; Gerakari S
Infect Dis (Lond); 2023 Oct; 55(10):706-715. PubMed ID: 37427461
[TBL] [Abstract][Full Text] [Related]
58. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
[TBL] [Abstract][Full Text] [Related]
59. Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy.
Boelig RC; Chaudhury S; Gromowski GD; Mayer S; King J; Aghai ZH; Bergmann-Leitner E
Front Immunol; 2023; 14():1216410. PubMed ID: 37753075
[TBL] [Abstract][Full Text] [Related]
60. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
